TVRD
Tvardi Therapeutics
TVRD
TVRD
71 hedge funds and large institutions have $102M invested in Tvardi Therapeutics in 2025 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
29% more funds holding
Funds holding: 55 → 71 (+16)
7.23% more ownership
Funds ownership: 20.78% → 28% (+7.2%)
Holders
71
Holding in Top 10
–
Calls
$1.72M
Puts
$73K
Top Buyers
| 1 | +$6.51M | |
| 2 | +$3.22M | |
| 3 | +$3.2M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$2.53M |
| 5 |
BlackRock
New York
|
+$2.42M |
Top Sellers
| 1 | -$583K | |
| 2 | -$80K | |
| 3 | -$67.1K | |
| 4 |
Morgan Stanley
New York
|
-$43.2K |
| 5 |
Citigroup
New York
|
-$42.1K |
